Galapagos NV
GLPG
#4956
Rank
โ‚น178.18 B
Marketcap
โ‚น2,653
Share price
0.00%
Change (1 day)
8.20%
Change (1 year)

Revenue for Galapagos NV (GLPG)

Revenue in 2026 (TTM): โ‚น109.71 Billion

According to Galapagos NV's latest financial reports the company's current revenue (TTM ) is โ‚น117.32 Billion. In 2025 the company made a revenue of โ‚น116.68 Billion an increase over the revenue in the year 2024 that were of โ‚น25.40 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Galapagos NV from 2015 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น109.71 B-5.97%
2025 โ‚น116.68 B359.21%
2024 โ‚น25.40 B147.77%
2023 โ‚น10.25 B-76.64%
2022 โ‚น43.89 B4.8%
2021 โ‚น41.88 B5.34%
2020 โ‚น39.76 B-39.94%
2019 โ‚น66.20 B181.28%
2018 โ‚น23.53 B152.86%
2017 โ‚น9.30 B-1.85%
2016 โ‚น9.48 B229.26%
2015 โ‚น2.88 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น9.219 T 7,758.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น4.318 T 3,580.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น5.851 T 4,887.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น5.306 T 4,423.05%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น6.292 T 5,263.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น5.782 T 4,829.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น4.225 T 3,501.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
โ‚น5.96 B-94.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.659 T 1,314.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel